1	female subject of nonchildbearing potential premenarcheal postmenopausal for at least 2 year bilateral oophorectomy or tubal ligation and complete hysterectomy be eligible female subject of childbearing potential be eligible if they use medically accept contraceptive method oral or depot contraceptive|contraceptive[254,267]|||||oral[275,279]|||||64078|64078|contraceptive
1	female subject of nonchildbearing potential premenarcheal postmenopausal for at least 2 year bilateral oophorectomy or tubal ligation and complete hysterectomy be eligible female subject of childbearing potential be eligible if they use medically accept contraceptive method oral or depot contraceptive|contraceptive[289,302]||||||||||64078|64078|contraceptive
2	treatment with at least ethinylestradiol 30 ?g per intake use with an additional barrier contraception method monogamous relationship with vasectomized or female partner or double-barrier contraception be acceptable method the subject must understand the consequence and potential risk of inadequately|ethinylestradiol[327,343]|||30[344,346]|||||||4124|4124|ethinylestradiol
3	protect sexual activity be educate about and understand the proper use of contraceptive method and undertake to inform the investigator of any potential change in status abstinence will be consider a an acceptable method of contraception if the investigator can document that the subject agree to be compliant|contraceptive[679,692]||||||||||64078|64078|contraceptive
